loadpatents
name:-0.0051131248474121
name:-0.0085151195526123
name:-0.00044608116149902
Bottegoni; Giovanni Patent Filings

Bottegoni; Giovanni

Patent Applications and Registrations

Patent applications and USPTO patent grants for Bottegoni; Giovanni.The latest application filed is for "pyrazole derivatives as h4 antagonist compounds".

Company Profile
0.4.6
  • Bottegoni; Giovanni - Cambridge GB
  • Bottegoni; Giovanni - Genoa IT
  • Bottegoni; Giovanni - Genova IT
  • Bottegoni; Giovanni - Fano IT
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Pyrazole Derivatives As H4 Antagonist Compounds
App 20210300906 - Brown; Giles Albert ;   et al.
2021-09-30
Dual inhibitor compounds for use in the treatment of neurodegenerative disorders and alzheimer's disease
Grant 9,975,861 - Cavalli , et al. May 22, 2
2018-05-22
Diarylalkylamine REV-ERB antagonists and their use as medicaments
Grant 9,949,968 - Grimaldi , et al. April 24, 2
2018-04-24
Phenyl carbamates and their use as inhibitors of the fatty acid amide hydrolase (FAAH) enzyme and modulators of the D3 dopamine receptor (D3DR)
Grant 9,828,352 - Bottegoni , et al. November 28, 2
2017-11-28
Diarylalkylamine Rev-erb Antagonists And Their Use As Medicaments
App 20170136009 - Grimaldi; Benedetto ;   et al.
2017-05-18
Dual Inhibitor Compounds for Use in the Treatment of Neurodegenerative Disorders and Alzheimer's Disease
App 20170096406 - Cavalli; Andrea ;   et al.
2017-04-06
Diarylalkylamine REV-ERB antagonists and their use as medicaments
Grant 9,611,245 - Grimaldi , et al. April 4, 2
2017-04-04
Diarylalkylamine Rev-erb Antagonists And Their Use As Medicaments
App 20160237057 - Grimaldi; Benedetto ;   et al.
2016-08-18
Phenyl Carbamates And Their Use As Inhibitors Of The Fatty Acid Amide Hydrolase (faah) Enzyme And Modulators Of The D3 Dopamine Receptor (d3dr)
App 20160194296 - BOTTEGONI; Giovanni ;   et al.
2016-07-07
Inhibitors Of Anandamide Transport And Their Therapeutic Uses
App 20140163034 - Piomelli; Daniele ;   et al.
2014-06-12

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed